|
|
|
|
| LEADER |
00000nab a2200000 a 4500 |
| 001 |
vtls008876234 |
| 005 |
20260318142148.0 |
| 008 |
040806c2006 xo 0 slo |
| 015 |
|
|
|a SNBCL2005/5
|
| 035 |
|
|
|a SLK037857
|
| 040 |
|
|
|a SLKCL
|b slo
|c SNKBUCL
|e AACR2
|
| 041 |
1 |
|
|a slo
|b slo
|h eng
|
| 044 |
|
|
|a xo
|c SK
|
| 080 |
|
|
|a 616.894-085:615.214:616-036.8
|2 1981
|
| 100 |
1 |
|
|a Schneider, Lon S.
|4 aut
|9 1306432
|
| 245 |
1 |
0 |
|a Riziko úmrtia pri liečbe pacientov s demenciou atypickými antipsychotikami
|b metaanalýza randomizovaných placebom overovaných štúdií
|c Lon S. Schneider, Karen S. Dagerman, Philip Insel ; Štefan Trenkler
|
| 246 |
1 |
0 |
|a Risk of death with atypical antipsychotic drug treatment for dementia. Metaanalysis of randomized placebo-controlled trials
|
| 300 |
|
|
|b obr., tab.
|
| 504 |
|
|
|a Res. slov.
|
| 504 |
|
|
|a Bibliogr. odkazy
|
| 650 |
0 |
7 |
|a demencia
|2 MESH
|9 2444
|
| 650 |
0 |
7 |
|a Alzheimerova choroba
|2 MESH
|9 2416
|
| 650 |
0 |
7 |
|a antipsychotiká
|x účinky nežiadúce
|2 MESH
|9 869201
|
| 650 |
0 |
7 |
|a úmrtnosť
|2 MESH
|9 4663
|
| 650 |
0 |
7 |
|a riziko
|2 MESH
|9 19516
|
| 650 |
0 |
7 |
|a meta-analýza
|2 MESH
|9 1067396
|
| 650 |
0 |
7 |
|a farmakoterapia
|2 MESH
|9 14158
|
| 700 |
1 |
|
|a Dagerman, Karen S.
|4 aut
|9 1306433
|
| 700 |
1 |
|
|a Insel, Philip
|4 aut
|9 1306434
|
| 700 |
1 |
|
|a Trenkler, Štefan,
|d 1949-
|4 trl
|9 73171
|
| 773 |
0 |
|
|w SERIAL_GENERAL*000115*2006*006*002
|x 1210-4132
|t JAMA
|g Roč. 14, č. 2 (2006), s. 120-130
|
| 852 |
|
|
|a BA006
|
| 999 |
|
|
|c 2624971
|d 2626901
|